DexCom (DXCM) Tops Q2 EPS by 7c; Raises Outlook
Tweet Send to a Friend
DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.08, $0.07 better than the analyst estimate of $0.01. Revenue for the quarter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
